Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.

El Saghir NS, Zgheib NK, Assi HA, Khoury KE, Bidet Y, Jaber SM, Charara RN, Farhat RA, Kreidieh FY, Decousus S, Romero P, Nemer GM, Salem Z, Shamseddine A, Tfayli A, Abbas J, Jamali F, Seoud M, Armstrong DK, Bignon YJ, Uhrhammer N.

Oncologist. 2015 Apr;20(4):357-64. doi: 10.1634/theoncologist.2014-0364. Epub 2015 Mar 16.

PMID:
25777348
2.

Optimisation of the continuum of supportive and palliative care for patients with breast cancer in low-income and middle-income countries: executive summary of the Breast Health Global Initiative, 2014.

Distelhorst SR, Cleary JF, Ganz PA, Bese N, Camacho-Rodriguez R, Cardoso F, Ddungu H, Gralow JR, Yip CH, Anderson BO; Breast Health Global Initiative Global Summit on Supportive Care and Quality of Life Consensus Panel Members.

Lancet Oncol. 2015 Mar;16(3):e137-47. doi: 10.1016/S1470-2045(14)70457-7. Review.

PMID:
25752564
3.

Breast cancer in low and middle income countries (LMICs): a shifting tide in global health.

Anderson BO, Ilbawi AM, El Saghir NS.

Breast J. 2015 Jan-Feb;21(1):111-8. doi: 10.1111/tbj.12357. Epub 2014 Nov 29.

PMID:
25444441
4.

Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer.

Haroun F, Al-Shaar L, Habib RH, El-Saghir N, Tfayli A, Bazarbachi A, Salem Z, Shamseddine A, Taher A, Cascorbi I, Zgheib NK.

Cancer Chemother Pharmacol. 2015 Jan;75(1):207-14. doi: 10.1007/s00280-014-2632-4. Epub 2014 Nov 27.

PMID:
25428516
5.

Enhancing cancer care in areas of limited resources: our next steps.

El Saghir NS, Farhat RA, Charara RN, Khoury KE.

Future Oncol. 2014 Oct;10(12):1953-65. doi: 10.2217/fon.14.124. Review.

6.

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E; European School of Oncology; European Society of Medical Oncology.

Breast. 2014 Oct;23(5):489-502. doi: 10.1016/j.breast.2014.08.009. Epub 2014 Sep 20. No abstract available.

7.

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E.

Ann Oncol. 2014 Oct;25(10):1871-88. doi: 10.1093/annonc/mdu385. Epub 2014 Sep 18. No abstract available.

8.

miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study.

Nassar FJ, El Sabban M, Zgheib NK, Tfayli A, Boulos F, Jabbour M, El Saghir NS, Talhouk R, Bazarbachi A, Calin GA, Nasr R.

PLoS One. 2014 Sep 18;9(9):e107566. doi: 10.1371/journal.pone.0107566. eCollection 2014.

9.

Outcome of Breast Cancer Patients Treated outside of Clinical Trials.

El Saghir NS, Assi HA, Jaber SM, Khoury KE, Nachef Z, Mikdashi HF, El-Asmar NS, Eid TA.

J Cancer. 2014 Jun 3;5(6):491-8. doi: 10.7150/jca.9216. eCollection 2014.

10.

Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide.

El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L.

Am Soc Clin Oncol Educ Book. 2014:e461-6. doi: 10.14694/EdBook_AM.2014.34.e461.

11.

Management of Paclitaxel-induced hand-foot syndrome.

Assi HA, Ayoub ZA, Jaber SM, Sibai HA, El Saghir NS.

Breast Care (Basel). 2013 Jun;8(3):215-7. doi: 10.1159/000352097.

12.

Re: Tumor boards and the quality of cancer care.

El Saghir NS, Assi HA, Khoury KE, El Zawawy AM, Abbas JA, Eid TA.

J Natl Cancer Inst. 2013 Dec 4;105(23):1839. doi: 10.1093/jnci/djt312. Epub 2013 Nov 1. No abstract available.

13.

Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.

Ganz PA, Yip CH, Gralow JR, Distelhorst SR, Albain KS, Andersen BL, Bevilacqua JL, de Azambuja E, El Saghir NS, Kaur R, McTiernan A, Partridge AH, Rowland JH, Singh-Carlson S, Vargo MM, Thompson B, Anderson BO.

Breast. 2013 Oct;22(5):606-15. doi: 10.1016/j.breast.2013.07.049. Epub 2013 Sep 3. Review.

14.

Epidemiology and prognosis of breast cancer in young women.

Assi HA, Khoury KE, Dbouk H, Khalil LE, Mouhieddine TH, El Saghir NS.

J Thorac Dis. 2013 Jun;5 Suppl 1:S2-8. doi: 10.3978/j.issn.2072-1439.2013.05.24.

15.

Pharmacogenomics variation in drug metabolizing enzymes and transporters in relation to docetaxel toxicity in Lebanese breast cancer patients: paving the way for OMICs in low and middle income countries.

Awada Z, Haider S, Tfayli A, Bazarbachi A, El-Saghir NS, Salem Z, Shamseddine A, Taher A, Zgheib NK.

OMICS. 2013 Jul;17(7):353-67. doi: 10.1089/omi.2013.0019. Epub 2013 Jun 11.

PMID:
23758476
16.

ASCO's International programs and how you can become involved.

El Saghir NS, Assi HA, Pyle D.

Am Soc Clin Oncol Educ Book. 2013:405-10. doi: 10.1200/EdBook_AM.2013.33.405.

17.

Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.

Zgheib NK, Shamseddine AA, Geryess E, Tfayli A, Bazarbachi A, Salem Z, Shamseddine A, Taher A, El-Saghir NS.

Mutat Res. 2013 Jul-Aug;747-748:40-7. doi: 10.1016/j.mrfmmm.2013.04.004. Epub 2013 Apr 27.

PMID:
23628324
18.

Modern cancer management and research in the Middle East.

El Saghir NS.

Lancet Oncol. 2012 Nov;13(11):1076-8. doi: 10.1016/S1470-2045(12)70479-5. Epub 2012 Oct 19. No abstract available. Erratum in: Lancet Oncol. 2012 Dec;13(12):e520.

PMID:
23084765
19.

Breast cancer early detection and resources: where in the world do we start?

El Saghir NS, Anderson BO.

Breast. 2012 Aug;21(4):423-5. doi: 10.1016/j.breast.2012.06.007. Epub 2012 Jul 4. No abstract available.

PMID:
22765980
20.

1st International consensus guidelines for advanced breast cancer (ABC 1).

Cardoso F, Costa A, Norton L, Cameron D, Cufer T, Fallowfield L, Francis P, Gligorov J, Kyriakides S, Lin N, Pagani O, Senkus E, Thomssen C, Aapro M, Bergh J, Di Leo A, El Saghir N, Ganz PA, Gelmon K, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Leadbeater M, Mayer M, Rodger A, Rugo H, Sacchini V, Sledge G, van't Veer L, Viale G, Krop I, Winer E.

Breast. 2012 Jun;21(3):242-52. doi: 10.1016/j.breast.2012.03.003. Epub 2012 Mar 16.

PMID:
22425534
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk